Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

ConditionOropharynx Cancer

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age40+

SponsorThe Institute of Molecular and Translational Medicine, Czech Republic

About this trial

This study defines the prevalence of oral infection with high-risk human papillomaviruses (hrHPV) in individuals over 40 years of age in the Czech Republic. It also establishes an effective methodology for oropharyngeal carcinoma screening and optimization of screening and testing procedures.

Eligibility criteria

Qualifiers

Participants aged 40 years or older at the time of enrollment.

Individuals who are capable of rinsing the oral cavity by gargling independently.

Signed informed consent for study participation, molecular-genetic testing, and personal data processing.

Disqualifiers

None

Trial design

Treatments tested in this trial

Self-sampling by gargling kit at dental clinic
Questionnaire
Self-sampling by gargling kit at home
Blood sampling
Self-sampling of the urogenital area

Treatment groups

20,000 Participants

are divided into 2 treatment groups

Sponsors and collaborators

The Institute of Molecular and Translational Medicine, Czech Republic

Lead sponsor

National Institute for Cancer Research, Czech Republic

Collaborator

Source ClinicalTrials.gov